6.18 USD
▼+1.05-2.37%
盘后 6.24 -1.42%
2026-08-03
市值
$4.45M
市盈率
—
EPS
-80.11
股息率
—
52 周区间
5.02 – 95.60
成交量
62.05K
Beta
0.23
目标价
160.00
52W 低 5.0252W 高 95.60
价格走势
公司简介
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO to treat viral lung infections, such as viral community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM). In addition, the company develops ultra-h...